CClinicalTrials.gg
Not yet recruitingNCT06426004NPHUpdated May 7, 2026

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

An interventional study of patients will receive NPH education and primary care physicians (PCPs) will receive professional NPH education in Normal Pressure Hydrocephalus and Hakim Syndrome, sponsored by Johns Hopkins Bloomberg School of Public Health. Not yet recruiting at 2 sites in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-07.

Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
660
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary Care Providers, and community health workers to enhance care access. Short-term outcomes will measure referrals to specialists, while long-term outcomes will assess healthcare utilization. The study aims to identify and reduce racial disparities in NPH care access, informing intervention strategies for NPH and other surgical areas.

Read the detailed description

This proposal responds to an established need for developing an evidence-based and community-informed approach to address health disparities in specialty surgical clinics where barriers to accessing care are multiplied along each level of the referral pathway. The study will focus on Normal Pressure Hydrocephalus (NPH) related care - a clinical syndrome characterized excess cerebrospinal fluid (CSF) in the brain resulting in symptoms of falls, dementia, and urinary incontinence, that is treated surgically by shunting to remove excess fluid from the brain. This disorder afflicts an estimated about 750,000 Americans, and prevalence increases with age. Limited information regarding racial and socioeconomic contributing factors associated with diagnosis and treatment is available.

Studies show NPH goes underdiagnosed in the USA. In the first part of the study the investigators will estimate NPH prevalence, the health equity gap in Baltimore and greater Maryland (MD), the health equity gap based on Zip Code as a marker of sociodemographic community status, and the health equity gap based on race, looking at the Black community, which comprises over 60% of the Baltimore and 30% in MD population. In the second part of the study, the investigators will develop three layers of interventions that involve educational elements about NPH and evaluate which provides the most benefit including referrals to NPH related care. 1) Patients identified from the first part of the study with possible NPH symptoms will receive intervention 2) Patients, and the Primary Care Providers (PCPs) receive intervention, and 3) patients, and PCP receive intervention and with additional community health workers (CHWs) assisting providers with managing the patient care including referrals, addressing socioeconomic barriers, transportation to receive care.

The success of these interventions will be evaluated by short-term outcomes such as referrals to specialists including neurologists and neurosurgeons every 6 months, and long-term outcomes such as healthcare utilization including screening for shunt surgery within 12 months. This study aims to identify racial disparities in access to NPH care and intervention outcomes will evaluate the effect of different interventions on reducing racial disparities and to help developing a referral system to address the needs of most vulnerable population and Zip Codes in Baltimore and greater MD. Using the results of this study will help to identify gaps, understand the best intervention, and develop intervention strategies not only for NPH but potentially other surgical areas.

02

Conditions studied

  • Normal Pressure Hydrocephalus
  • Hakim Syndrome
03

In context

Hydrocephalus, Normal Pressure

71 studies on the registry are indexed under Hydrocephalus, Normal Pressure; 17 are open to participants now.

This study's planned enrollment of 660 is above the median of 50 across 37 interventional studies indexed under Hydrocephalus, Normal Pressure.

Browse Hydrocephalus, Normal Pressure studies →

Lead sponsor

Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 364 studies on the registry; 41 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • People over 65 years old who have completed the Annual Wellness Survey (AWV) survey
  • have a clinical profile in the Hopkins Epic data sets
  • live in Maryland

Exclusion criteria

Exclusion Criteria:

  • People under 65 years old will be excluded if they have not completed the AWV survey
  • do not live in Maryland

Community Health Worker (CHW) Inclusion Criteria:

  • certified Community Health Workers from Maryland
  • completed accredited training by the Maryland Department of Health

Primary Care Physician inclusion criteria:

  • must have patients in Johns Hopkins University AWV
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
660 participants (estimated)

Study arms

  • Experimental
    Patients and the patient's family

    All patients and the patient's family will receive NPH-related education.

    Other: patients will receive NPH education · Other: primary care physicians (PCPs) will receive professional NPH education · Other: A community health worker will assist PCP

  • Experimental
    PCPs Training

    Primary Care Provider (PCP) will receive NPH education.

    Other: primary care physicians (PCPs) will receive professional NPH education · Other: A community health worker will assist PCP

  • Experimental
    CHWs assist PCPs

    A community health worker (CHW) will assist PCP.

    Other: A community health worker will assist PCP

Interventions

  • Otherpatients will receive NPH education

    Patients will benefit from the Hydrocephalus Association's (HA) educational strategy for idiopathic normal pressure hydrocephalus (iNPH) emphasizes patient collaboration in the development of educational materials specifically for this condition. HA has a library of assets that include PowerPoint presentations, videos, and online and print educational materials. There will be also in-person outreach resulting recruitment, website (the study website and HA website), webform (with a symptom of gait, dementia, and bladder symptoms), YouTube videos. The investigators will also go to the communities like senior centers, health fair, and churches, then we will give a talk about iNPH. These resources will be carefully adjusted to suit low-income demographics, guided by feedback from Baltimore audiences and HA's iNPH volunteers.

  • Otherprimary care physicians (PCPs) will receive professional NPH education

    A comprehensive professional development program for PCPs and CHWs, featuring presentations, educational videos, webinars, and tools on iNPH diagnosis, treatment, and care management. Provider Continuing Medical Education (CME) credits will be offered for in-person lectures, aiming to equip PCPs with the skills needed to address iNPH in low-income settings effectively

  • OtherA community health worker will assist PCP

    A community health worker will assist PCP to identify barriers and help overcome these barriers in order for patient to access iNPH care.

06

What researchers measure

Primary outcomes

  1. number of referrals

    number of referrals for suspicion of NPH to neurologists or neurosurgeons

    Time frame: 6 months

  2. number of screenings

    number of screenings for shunt surgery

    Time frame: 12 months

  3. number of screenings

    number of screenings for shunt surgery

    Time frame: 24 months

Secondary outcomes

  1. number of NPH's consultations

    number of patients who have received a consultation

    Time frame: 24 months

Other outcomes

  1. number of referrals

    referrals for physical therapy, occupational therapy, psychiatry, neurology - movement disorder specialist, neurology neuropathy specialist, orthopedic surgery, neurosurgery- spine specialist, neuropsychologist

    Time frame: 12 months and 24 months

07

Study locations

2 sites
  • Johns Hopkins University and Hospital
    Baltimore, Maryland 21205, United States
    • Hossein Zare, MS, PhD · Contact · hzare1@jhu.edu · 410-614-7246
    • Mark G Luciano, PhD, FACS · Contact · markluciano@jhu.edu
    • Hossein Zare, MS, PhD · Principal investigator
    • Mark G Luciano, MD, PhD · Principal investigator
    • Sevil Yasar, MD, PhD · Principal investigator
    • Darrell Gaskin, MS, PhD · Sub investigator
    • Taiwo Akindahunsi, MD · Sub investigator
    • Michelle Spencer, MS · Sub investigator
    • Jiangxia Wang, MA, MS · Sub investigator
    • Amanda Garzon, MIA · Sub investigator
    • Roger Clark · Sub investigator
  • Johns Hopkins University
    Baltimore, Maryland 21205, United States
08

References and documents

Individual participant data

Plan to share: Yes — The study protocol and analytic plan will be freely available. In addition to analytical files, the Stata, Statistical Analysis System (SAS), R codes and programs and data dictionary will be available to researchers approved by one of the study's Principal Investigators to receive data. All papers must include an acknowledgment section that includes the funding source.

Supporting information: Sap, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06426004
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Responsible party
Sponsor
First posted
May 23, 2024
Start date
Aug 1, 2027 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Mar 30, 2032 (estimated)
Last update
May 7, 2026

Study contacts

Hossein Zare, MS, PhD
Contact
hzare1@jhu.edu
4106147246
Mark G Luciano, PhD, FACS
Contact
markluciano@jhu.edu
Hossein Zare, PhD
principal investigator · Johns Hopkins Bloomberg School of Public Health

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion